Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Main Content

Journal CME

Journal CME 36.09: Cortical [18F]PI-2620 Binding Differentiates Corticobasal Syndrome Subtypes

Length:60 MinutesCME Credits:1Release Date:Sep 30, 2021

Expert / AdvancedJournal CME

Program Description

The Journal CME 36.09 article provided an investigation into the diagnostic value of the tau PET-ligand [18F]PI-2620 in patients with corticobasal syndrome.

Topics

  • Basic/Translational Neuroscience
  • Etiology & Pathophysiology
  • Parkinson Disease/Hypokinetic Movement Disorders

Faculty

Carla Palleis, MD

Course Purpose

Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.

Learning Objectives

Upon completion of this activity learners will be able to:

1. Understand the association of corticobasal syndrome with cerebral protein aggregates
2. Assess how imaging can be a useful biomarker for the evaluation of corticobasal syndrome
3. Evaluate the results and how [18F]PI-2620 may potentially serve for a differential diagnosis and for monitoring disease progression

Intended Audience

This activity is intended for physicians, fellows or other practitioners in the field of Movement Disorders with an emphasis on current practice trends.

Accreditation Credit

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.

 

Credit Designation Statement

The International Parkinson and Movement Disorder Society designates this education activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Method of Participation

Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.

Faculty Disclosure

All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available below. All relevant financial relationships have been mitigated in advance of this program.

 

Sara SchaeferCourse Director
Nothing to Disclose


Veronica SantiniReviewer
Grant: Insightec, Biogen, Roche / Genentech


Carla Palleis: Author
Nothing to disclose


Matthias Brendel: Author
Speaker honoraria from GE Healthcare and LMI and is an adviser of LMI


Anika FinzeAuthor
Nothing to disclose


Endy Weidinger: Author
Nothing to disclose


Kai Bötzel: Author
Nothing to disclose


Adrian Danek: Author
Nothing to disclose


Leonie Beyer: Author
Nothing to disclose


Alexander Nitschmann: Author
Nothing to disclose


Maike Kern: Author
Nothing to disclose


Gloria Biechele: Author
Nothing to disclose


Boris-Stephan Rauchmann: Author
Nothing to disclose


Jan Häckert: Author
Nothing to disclose


Matthias Höllerhage: Author
Nothing to disclose


Andrew W. Stephens: Author
Employee: LMI


Alexander Drzezga: Author
Nothing to disclose


Thilo van Eimeren: Author
Nothing to disclose


Victor L. Villemagne: Author
Nothing to disclose


Andreas Schildan: Author
Nothing to disclose


Henryk Barthel: Author
Nothing to disclose


Marianne Patt: Author
Nothing to disclose


Osama Sabri: Author
Research funding: LMI


German Imaging Initiative for Tauopathies (GII4T): Author
Nothing to disclose


Peter Bartenstein: Author
Nothing to disclose


Robert Perneczky: Author
Advisory board: Biogen; Consultant: Eli Lilly; Grant Recipient: Janssen Pharmaceutica and Boehringer Ingelheim; Speaker honoraria: Janssen-Cilag, Pfizer, and Biogen


Christian Haass: Author
Chief Scientific Adviser of ISAR Biosciences; Collaboration: DENALI Therapeutics


Johannes Levin: Author
Speaker fee: Bayer Vital; Consulting fee: Axon Neuroscience; Author fee: Thieme medical publishers and W. Kohlhammer GmbH medical publishers; Nonfinancial support: AbbVie, Part-time CMO from MODAG GmbH, all outside the submitted work


Günter U. Höglinger: Author
Research collaboration: Prothena; Consultant: AbbVie, AlzProtect, Asceneuron, Biogen, Biohaven, Lundbeck, Novartis, Roche, Sanofi, UCB; Honoraria: AbbVie, Bial, Biogen, Bristol Myers Squibb, Roche, Teva, UCB, and Zambon; Patent: PERK Activation for the Treatment of Neurodegenerative Diseases (PCT/EP2015/068734)

Staff Disclosure

MDS staff members involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Hardware and Software Requirements

1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher).
5. Adobe Reader to print certificate.

Contact Us

MDS Education

MDS Secretariat Liaison

Ericka Blackford

Disclaimer

All individuals in control of content for this course are required to disclose all relevant financial relationships with commercial interests as defined by the ACCME.

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice